|Videos|August 2, 2021
Roundtable: Synthetic Control Arms and Regulatory/HTA Requirements
Author(s)Parexel
Advertisement
A roundtable discussing the opportunities that synthetic control arms offer for patients and product developers, and how to overcome potential barriers with the use of this burgeoning clinical trial model.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Evolving Relationship Between FDA and Biotech
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson & Johnson Enters Collaboration with Department of Health - Abu Dhabi
4
The Implications of GLP-1s Replacing Oncology as the Key Value Driver
5